HemaSphere (Aug 2023)
P727: REFINING RISK STRATIFICATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): A COMPREHENSIVE ASSESSMENT OF THE IPSS-M AND OTHER MOLECULARLY INTEGRATED PROGNOSTIC MODELS
- Luis E. Aguirre,
- Akriti Jain,
- Somedeb Ball,
- Najla Al Ali,
- David Sallman,
- Andrew Kuykendall,
- Onyee Chan,
- Zhuoer Xie,
- Alison Walker,
- Kendra Sweet,
- Jeffrey Lancet,
- Eric Padron,
- Rami S. Komrokji
Affiliations
- Luis E. Aguirre
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Akriti Jain
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Somedeb Ball
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Najla Al Ali
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- David Sallman
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Andrew Kuykendall
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Onyee Chan
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Zhuoer Xie
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Alison Walker
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Kendra Sweet
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Jeffrey Lancet
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Eric Padron
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- Rami S. Komrokji
- 1 H. Lee Moffitt Cancer Center, Department of Malignant Hematology, Tampa, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000969812.65557.34
- Journal volume & issue
-
Vol. 7
p. e6555734
Abstract
No abstracts available.